NERVGEN PHARMA CORP. Rightofuse Assets
NERVGEN PHARMA CORP. (NGEN) had Rightofuse Assets of CAD 187.42 thousand as of 2023-12-31, per its 40-F filed 2026-03-31.
Financial Statements › Notes
ifrs-full:RightofuseAssets · last filed 2026-03-31
- 2023-12-31: Rightofuse Assets 187.42K CAD.
| Period end | Rightofuse Assets |
|---|---|
| 2023-12-31 | 187.42K CAD 40-F · filed 2026-03-31 |